A survey of recent patents on CB2 agonists in the management of pain.

Gabriele Murineddu, Battistina Asproni, Gerard A Pinna
{"title":"A survey of recent patents on CB2 agonists in the management of pain.","authors":"Gabriele Murineddu,&nbsp;Battistina Asproni,&nbsp;Gerard A Pinna","doi":"10.2174/157488912798842214","DOIUrl":null,"url":null,"abstract":"<p><p>Pain, a homeostatic and protective mechanism which can go awry in disease states and therefore needs treatment, is a complex and differentiated sensorial perception which may be classified as physiological, inflammatory and neuropathic. Chronic pain represents a major health problem throughout the world, thus several companies and researchers have embarked on the search for new drugs and targets to treat the disease. The different types of receptors in the CNS involved in the mediation of analgesia include the cannabinoid receptors: in particular, CB2 modulators seem to represent a new potential class of analgesic. This review covers recent patents and advances in CB2 agonist studies in the management of pain.</p>","PeriodicalId":87737,"journal":{"name":"Recent patents on CNS drug discovery","volume":"7 1","pages":"4-24"},"PeriodicalIF":0.0000,"publicationDate":"2012-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/157488912798842214","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on CNS drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/157488912798842214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

Abstract

Pain, a homeostatic and protective mechanism which can go awry in disease states and therefore needs treatment, is a complex and differentiated sensorial perception which may be classified as physiological, inflammatory and neuropathic. Chronic pain represents a major health problem throughout the world, thus several companies and researchers have embarked on the search for new drugs and targets to treat the disease. The different types of receptors in the CNS involved in the mediation of analgesia include the cannabinoid receptors: in particular, CB2 modulators seem to represent a new potential class of analgesic. This review covers recent patents and advances in CB2 agonist studies in the management of pain.

最近关于CB2激动剂治疗疼痛的专利调查。
疼痛是一种复杂的、分化的感觉知觉,可分为生理性、炎症性和神经性,是一种体内平衡和保护机制,在疾病状态下可能出错,因此需要治疗。慢性疼痛在全世界都是一个主要的健康问题,因此一些公司和研究人员已经开始寻找新的药物和目标来治疗这种疾病。中枢神经系统中参与镇痛介导的不同类型的受体包括大麻素受体:特别是CB2调节剂似乎代表了一种新的潜在镇痛药。本文综述了CB2激动剂治疗疼痛的最新专利和进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书